Voyager Therapeutics (VYGR) Tops Q4 EPS by 5c
Tweet
Share
E-mailGet Alerts VYGR Hot Sheet
Join SI Premium – FREE
Voyager Therapeutics (NASDAQ: VYGR) reported Q4 EPS of ($0.46), $0.05 better than the analyst estimate of ($0.51). Revenue for the quarter came in at $15.34 million versus the consensus estimate of $9.19 million.
For earnings history and earnings-related data on Voyager Therapeutics (VYGR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- Ulta Beauty (ULTA) Tops Q2 EPS by 38c, Offers Outlook
- Deutsche Bank Starts Rhythm Pharmaceuticals (RYTM) at Hold
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
